Is Long-Term Anti-Osteoporotic Treatment Associated with Greater Risk of Cancer in People with Severe Vertebral Fractures? A Hospital-Based Cohort Study

J Am Geriatr Soc. 2015 Nov;63(11):2418-9. doi: 10.1111/jgs.13798.
No abstract available

Publication types

  • Clinical Study
  • Letter

MeSH terms

  • Aged
  • Alendronate / adverse effects
  • Bone Density Conservation Agents / adverse effects*
  • Bone Density Conservation Agents / therapeutic use
  • Calcitonin / administration & dosage
  • Cohort Studies
  • Female
  • Hospitalization
  • Humans
  • Injury Severity Score
  • Male
  • Neoplasms / chemically induced*
  • Neoplasms / epidemiology
  • Osteoporosis / complications
  • Osteoporosis / drug therapy*
  • Osteoporotic Fractures / etiology
  • Risk Assessment
  • Spinal Fractures / etiology
  • Teriparatide / adverse effects
  • Time Factors

Substances

  • Bone Density Conservation Agents
  • Teriparatide
  • Calcitonin
  • Alendronate